Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonali M Smith

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Clinical Advances in Hematology & Oncology : H&O|February 15, 2011
Galiximab in relapsed hodgkin lymphomaSonali M Smith
Blood|December 18, 2010
AIDS-related BL and CD4 count: a clue?Sonali M Smith
Leukemia & Lymphoma|June 12, 2012
Maintenance rituximab revisited: is it worth the cost?Sonali M Smith
Hematological Oncology|June 8, 2017
Treatment of aggressive B-cell lymphomasSonali M Smith
Clinical Advances in Hematology & Oncology : H&O|October 12, 2021
Evolving strategies for the management of transformed lymphomaSonali M Smith
Haematologica|September 7, 2023
When more is just more, not better: a recurring lessonSonali M Smith
Reviews on Recent Clinical Trials|May 14, 2008
Clinical development of mTOR inhibitors: a focus on lymphomaSonali M Smith
Hematological Oncology|June 15, 2025
Marginal Zone Lymphoma: Treatment Update With a Focus on Systemic ApproachesSonali M Smith
Current Treatment Options in Oncology|August 29, 2003
Nonmyeloablative transplantation for lymphomaSonali M Smith
Current Treatment Options in Oncology|August 19, 2006
Reduced-intensity transplantation for lymphomaSonali M Smith
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Clinical Advances in Hematology & Oncology : H&O|February 15, 2011
Galiximab in relapsed hodgkin lymphomaSonali M Smith
Blood|December 18, 2010
AIDS-related BL and CD4 count: a clue?Sonali M Smith
Leukemia & Lymphoma|June 12, 2012
Maintenance rituximab revisited: is it worth the cost?Sonali M Smith
Hematological Oncology|June 8, 2017
Treatment of aggressive B-cell lymphomasSonali M Smith
Clinical Advances in Hematology & Oncology : H&O|October 12, 2021
Evolving strategies for the management of transformed lymphomaSonali M Smith
Haematologica|September 7, 2023
When more is just more, not better: a recurring lessonSonali M Smith
Reviews on Recent Clinical Trials|May 14, 2008
Clinical development of mTOR inhibitors: a focus on lymphomaSonali M Smith
Hematological Oncology|June 15, 2025
Marginal Zone Lymphoma: Treatment Update With a Focus on Systemic ApproachesSonali M Smith
Current Treatment Options in Oncology|August 29, 2003
Nonmyeloablative transplantation for lymphomaSonali M Smith
Current Treatment Options in Oncology|August 19, 2006
Reduced-intensity transplantation for lymphomaSonali M Smith
Pageof 22